#ESMO21 : CDK4/6 inhibitors have led to a paradigm shift in the treatment of HR-positive/HER2-negative #aBC , offering patients the opportunity to live significantly longer and better lives. Editorial by @CarmenCriscit 👉 #bcsm #advancedbreastcancer